| First Author | Wu J | Year | 2019 |
| Journal | Int J Cancer | Volume | 144 |
| Issue | 9 | Pages | 2239-2253 |
| PubMed ID | 30450584 | Mgi Jnum | J:336905 |
| Mgi Id | MGI:6844646 | Doi | 10.1002/ijc.32000 |
| Citation | Wu J, et al. (2019) Molecular and cellular basis of mammary gland fibrosis and cancer risk. Int J Cancer 144(9):2239-2253 |
| abstractText | Mammary gland luminal cells are maintained by the proliferation of ER- luminal progenitor (LP) cells. Human breast LP cells exhibit telomere DNA damage, which is associated with mammographic density and increased cancer risk. Telomeric repeat factor 2 (TRF2) protects telomeres from DNA damage response. TRF2 expression is reduced in human breast cancers. We deleted TRF2 expression in mammary gland epithelium. Mammary glands lacking TRF2 expression exhibited increased telomere DNA damage response, histopathological and functional degeneration, and prominent ductal fibrosis. TRF2-deficient mammary tumors exhibited rapid onset and increased proliferation. Tumor derived LP cells failed to form tumors after transplantation. The MSC population was highly tumorigenic and maintained telomeres via the ALT mechanism. Telomere DNA damage response in mammary tumors resulted in p53 dependent ER+ cellular differentiation and sensitivity to anti-estrogen therapy. Our results provide a new in vivo model of mammographic density, stem cell differentiation, cancer risk, and therapeutic sensitivity. |
